Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.smslife.in | |
Market Cap | 189.68 Cr. | |
Enterprise Value(EV) | 275.25 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 53.47 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 11.78 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.78 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 538.66 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.17 | Calculated using Price: 629.80 |
Dividend Yield | 0.24 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.30 Cr. | 3,023,287 Shares |
FaceValue | 10 | |
Company Profile | ||
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates. |
1 Day |
|
+1.74% |
1 Week |
|
+1.58% |
1 Month |
|
+0.32% |
3 Month |
|
-6.20% |
6 Month |
|
-8.86% |
1 Year |
|
-16.13% |
2 Year |
|
+12.27% |
5 Year |
|
+53.24% |
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 16.78 | 9.17 | 11.07 | 17.98 | |
Return on Capital Employed (%) | 20.14 | 11.91 | 12.96 | 18.42 | |
Return on Assets (%) | 6.45 | 3.83 | 4.82 | 7.54 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 106 | 116 | 129 | 152 | 163 | |
Non Curr. Liab. | 39 | 50 | 59 | 56 | 72 | |
Curr. Liab. | 132 | 90 | 119 | 143 | 121 | |
Minority Int. | 13 | 19 | ||||
Equity & Liab. | 276 | 256 | 307 | 364 | 375 | |
Non Curr. Assets | 128 | 146 | 176 | 201 | 228 | |
Curr. Assets | 149 | 110 | 131 | 164 | 147 | |
Misc. Exp. not W/O | ||||||
Total Assets | 276 | 256 | 307 | 364 | 375 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 378 | 261 | 266 | 350 | 350 | |
Other Income | 3 | 2 | 2 | 2 | 2 | |
Total Income | 380 | 263 | 267 | 352 | 352 | |
Total Expenditure | -343 | -235 | -235 | -316 | -319 | |
PBIDT | 37 | 28 | 32 | 36 | 34 | |
Interest | -6 | -5 | -5 | -6 | -7 | |
Depreciation | -6 | -8 | -8 | -10 | -10 | |
Taxation | -8 | -4 | -6 | -7 | -6 | |
Exceptional Items | 13 | 5 | ||||
PAT | 18 | 10 | 14 | 25 | 16 | |
Minority Interest | 0 | 0 | ||||
Share Associate | ||||||
Other Related Items | ||||||
Consolidated Net Profit | 18 | 10 | 14 | 25 | 16 | |
Adjusted EPS | 59 | 34 | 45 | 84 | 53 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 30 | 15 | 35 | -11 | |
Cash Fr. Inv. | -44 | -27 | -26 | -7 | |
Cash Fr. Finan. | 15 | 12 | -3 | 11 | |
Net Change | 1 | 0 | 6 | -8 | |
Cash & Cash Eqvt | 2 | 2 | 9 | 1 |
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 COMPLIANCE CERTIFICATE |
Wed, 28 Dec 2022
Closure of Trading Window INTIMATION OF TRADING WINDOW CLOSURE. |
Tue, 27 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for TVVSN Murthy (HUF) |
Mon, 30 Jan 2023 |
|
|
|
|
|